Randomized controlled trial on immunomodulatory Effects of Azithromycin in Children with Steroid Dependent Nephrotic Syndrome
Not Applicable
- Conditions
- complteted
- Registration Number
- JPRN-UMIN000035961
- Lead Sponsor
- Cairo University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 57
Inclusion Criteria
Not provided
Exclusion Criteria
- Patients have received immunosuppressive or cytotoxic drugs other than steroids. - Patients with impaired liver functions, or with baseline risk of cardiovascular disease (i.e. prolonged QT syndrome, abnormally slow heart rate, congenital or acquired cardiac diseases or low levels of potassium and magnesium) - Secondary nephrotic syndrome
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Comparison of TNF in both studied groups at different points throughout the study period.
- Secondary Outcome Measures
Name Time Method - Reported significant persistent adverse effects of AZM - Poor compliance of the patients - Occurrence of relapse